Preclinical Proof-of-Concept of AMT-260, a Novel AAV9-Dual microRNA-Based Vector Targeting GRIK2 for the Treatment of Temporal Lobe EpilepsyNick Pearson,Stephane Baudouin,Morgane Wartel,Sonay Keskin,Andrew C. Mercer,Olivier F. Danos, Chrsitophe Mulle,Nicolas Partouche,Valerie CrepelMOLECULAR THERAPY(2023)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要